Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/β-thalassemia patients
Chalikiopoulou, Constantina, Tavianatou, Anastasia-Gerasimoula, Sgourou, Argyro, Kourakli, Alexandra, Kelepouri, Dimitra, Chrysanthakopoulou, Maria, Kanelaki, Vasiliki-Kaliopi, Mourdoukoutas, Evangelos, Siamoglou, Stavroula, John, Anne, Symeonidis, Argyris, Ali, Bassam R, Katsila, Theodora, Papachatzopoulou, Adamantia, Patrinos, George P
Published in Pharmacogenomics (01.03.2016)
Published in Pharmacogenomics (01.03.2016)
Get full text
Journal Article
Genomic variants in the
Chalikiopoulou, Constantina, Tavianatou, Anastasia-Gerasimoula, Sgourou, Argyro, Kourakli, Alexandra, Kelepouri, Dimitra, Chrysanthakopoulou, Maria, Kanelaki, Vasiliki-Kaliopi, Mourdoukoutas, Evangelos, Siamoglou, Stavroula, John, Anne, Symeonidis, Argyris, Ali, Bassam R, Katsila, Theodora, Papachatzopoulou, Adamantia, Patrinos, George P
Published in Pharmacogenomics (01.03.2016)
Published in Pharmacogenomics (01.03.2016)
Get full text
Journal Article